Cargando…

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom

OBJECTIVES: The treatment paradigm in newly diagnosed multiple myeloma (NDMM) is evolving toward individualized, risk‐directed, and longer duration of therapy (DOT). The objective of this study was to describe treatment patterns and outcomes in non‐transplant NDMM in four European countries. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohty, Mohamad, Knauf, Wolfgang, Romanus, Dorothy, Corman, Shelby, Verleger, Katharina, Kwon, Youngmin, Cherepanov, Dasha, Cambron‐Mellott, M. Janelle, Vikis, Haris G., Gonzalez, Francisco, Gavini, Francois, Ramasamy, Karthik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497114/ https://www.ncbi.nlm.nih.gov/pubmed/32418256 http://dx.doi.org/10.1111/ejh.13439

Ejemplares similares

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
por: Ailawadhi, Sikander, et al.
Publicado: (2022)

Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022)

International Pharmaceutical Spending Controls: France, Germany, Sweden, and the United Kingdom
por: Gross, David J., et al.
Publicado: (1994)

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2013)

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Hechmati, Guy, et al.
Publicado: (2014)

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada
por: Smith-Palmer, J., et al.
Publicado: (2019)

The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2023)

Institutional environments and breakthroughs in science. Comparison of France, Germany, the United Kingdom, and the United States
por: Heinze, Thomas, et al.
Publicado: (2020)

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment
por: Kumar, Jinender, et al.
Publicado: (2021)

Factors associated with patient activation among individuals with depression within racial/ethnic groups in the United States
por: Janelle Cambron-Mellott, M., et al.
Publicado: (2023)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Emotional reactions to climate change: a comparison across France, Germany, Norway, and the United Kingdom
por: Böhm, Gisela, et al.
Publicado: (2023)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom
por: Bröckelmann, Paul J., et al.
Publicado: (2018)

COVID-19 and Territorial Policy Dynamics in Western Europe: Comparing France, Spain, Italy, Germany, and the United Kingdom
por: Vampa, Davide
Publicado: (2021)

Potato Production in Northwestern Europe (Germany, France, the Netherlands, United Kingdom, Belgium): Characteristics, Issues, Challenges and Opportunities
por: Goffart, Jean-Pierre, et al.
Publicado: (2022)

Economic and Humanistic Burden of Cervical Cancer in the United States: Results from a Nationally Representative Survey
por: Shah, Ruchit, et al.
Publicado: (2020)

Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study
por: Escalada, Javier, et al.
Publicado: (2020)

Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany
por: Klapproth, Christoph Paul, et al.
Publicado: (2020)

The Baths of Germany, France, and Switzerland
Publicado: (1857)

The Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1859)

Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment
por: Yong, Candice, et al.
Publicado: (2022)

The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study
por: Goring, S. M., et al.
Publicado: (2018)

Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom
por: Liu, Z., et al.
Publicado: (2021)

Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
por: He, Jianming, et al.
Publicado: (2021)

Large-Scale In Silico Mapping of Complex Quantitative Traits in Inbred Mice
por: Liu, Pengyuan, et al.
Publicado: (2007)

The Asylums of Italy, Germany, and France, &c.
por: Arlidge, J. T.
Publicado: (1858)

Notes on the Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1860)

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study
por: Darbà, Josep, et al.
Publicado: (2015)

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
por: Vo, Pamela, et al.
Publicado: (2018)

A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom
por: Rigoine de Fougerolles, Thierry, et al.
Publicado: (2021)

Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment
por: Cambron-Mellott, M Janelle, et al.
Publicado: (2021)

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan
por: Leith, Andrea, et al.
Publicado: (2022)

Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom
por: Boudewijns, Bronke, et al.
Publicado: (2022)

Quotas, and Anti‐discrimination Policies Relating to Autism in the EU: Scoping Review and Policy Mapping in Germany, France, Netherlands, United Kingdom, Slovakia, Poland, and Romania
por: Bunt, Danielle, et al.
Publicado: (2020)

P936: EXPLORING HETEROGENEITY IN TREATMENT PREFERENCES OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE UNITED STATES, UNITED KINGDOM, FRANCE, SPAIN, ITALY AND GERMANY
por: Popat, Rakesh, et al.
Publicado: (2023)

P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
por: Ramasamy, Karthik, et al.
Publicado: (2023)

Cancer Organizations in France, Belgium, England, Germany and Sweden
por: Spies, John W.
Publicado: (1931)

Mr. Lee on the Medical Institutions of France, Germany, and Italy
Publicado: (1836)

Cannot write session to /tmp/vufind_sessions/sess_car7u805gvh1tjl78pherlu11u